{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:09:47Z","timestamp":1763017787065,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.bbmt.2017.08.010","type":"journal-article","created":{"date-parts":[[2017,8,12]],"date-time":"2017-08-12T07:31:31Z","timestamp":1502523091000},"page":"2151-2158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["A New Clinicobiological Scoring System for the Prediction of Infection-Related Mortality and Survival after Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"23","author":[{"given":"Alessandra","family":"Forcina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola M.V.","family":"Rancoita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magda","family":"Marcatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Greco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Lupo-Stanghellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Carrabba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Marasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clelia","family":"Di Serio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacopo","family":"Peccatori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Consuelo","family":"Corti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attilio","family":"Bondanza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Ciceri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2017.08.010_bib0010","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1126\/science.276.5319.1719","article-title":"HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia","volume":"276","author":"Bonini","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0015","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(09)70074-9","article-title":"Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study","volume":"10","author":"Ciceri","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0020","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1182\/blood-2006-05-023416","article-title":"Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation","volume":"109","author":"Ciceri","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0025","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood-2015-04-639831","article-title":"Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia","volume":"126","author":"Ciurea","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0030","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/leu.2014.336","article-title":"A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia","volume":"29","author":"Piemontese","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0035","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0040","first-page":"1238","article-title":"Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation","volume":"89","author":"Bacigalupo","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0045","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.bmt.1705140","article-title":"Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time","volume":"36","author":"Gratwohl","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0050","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/bmt.2014.231","article-title":"Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy","volume":"50","author":"Girmenia","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0055","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1200\/JCO.2010.28.8852","article-title":"Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure","volume":"28","author":"Duval","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0060","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.bbmt.2007.07.007","article-title":"Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor","volume":"13","author":"Robin","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0065","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/tid.12175","article-title":"Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations","volume":"16","author":"Blennow","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0070","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MOH.0000000000000086","article-title":"Epidemiology and risk factors for invasive fungal diseases in hematopoietic stem cell transplantation","volume":"21","author":"Girmenia","year":"2014","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0075","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1399-3062.2010.00544.x","article-title":"Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients","volume":"12","author":"Mikulska","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0080","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.bbmt.2008.04.011","article-title":"Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromes","volume":"14","author":"Scott","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"Suppl 5","key":"10.1016\/j.bbmt.2017.08.010_bib0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1398-2265.2004.00183.x","article-title":"Recent advances in the prevention of CMV infection and disease after hematopoietic stem cell transplantation","volume":"8","author":"Boeckh","year":"2004","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0090","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1182\/blood-2012-03-418202","article-title":"A disease risk index for patients undergoing allogeneic stem cell transplantation","volume":"120","author":"Armand","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0095","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0100","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.anai.2009.11.009","article-title":"Innate and adaptive immunosenescence","volume":"104","author":"Agarwal","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0110","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1200\/JCO.2013.53.8157","article-title":"Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation","volume":"32","author":"Sorror","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0115","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1182\/blood-2002-10-3263","article-title":"Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis","volume":"102","author":"Ljungman","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/338624","article-title":"High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection","volume":"185","author":"Nichols","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0125","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.beha.2006.09.003","article-title":"Risk assessment in haematopoietic stem cell transplantation: viral status","volume":"20","author":"Ljungman","year":"2007","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0130","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood.V98.7.2043","article-title":"Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age","volume":"98","author":"Kollman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0135","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1182\/blood-2013-05-499830","article-title":"CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT","volume":"122","author":"Schmidt-Hieber","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0140","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood-2015-11-679639","article-title":"Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis","volume":"127","author":"Teira","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0145","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/bmt.2016.352","article-title":"Recipient\/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor hematopoietic cell transplants","volume":"52","author":"Shaw","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0150","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/cid\/ciu364","article-title":"Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European Group for Blood and Marrow Transplantation","volume":"59","author":"Ljungman","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0155","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrd984","article-title":"Therapeutic antibodies for human diseases at the dawn of the twenty-first century","volume":"2","author":"Brekke","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0160","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jcrc.2005.03.003","article-title":"Cost-effectiveness of immunoglobulin M-enriched immunoglobulin (Pentaglobin) in the treatment of severe sepsis and septic shock","volume":"20","author":"Neilson","year":"2005","journal-title":"J Crit Care"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.bmt.1704085","article-title":"A revised day +7 predictive score for transplant-related mortality: serum cholinesterase, total protein, blood urea nitrogen, gamma glutamyl transferase, donor type and cell dose","volume":"32","author":"Sormani","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0170","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ni.2608","article-title":"Control of pathogens and pathobionts by the gut microbiota","volume":"14","author":"Kamada","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0175","first-page":"451","article-title":"Use of IgM enriched intravenous immunoglobulin (Pentaglobin) in bone marrow transplantation","volume":"9","author":"Poynton","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0180","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2362.1993.tb00963.x","article-title":"Effect of IgM-enriched intravenous immunoglobulin (Pentaglobin) on endotoxaemia and anti-endotoxin antibodies in bone marrow transplantation","volume":"23","author":"Jackson","year":"1993","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.bbmt.2017.08.010_bib0185","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/petr.12636","article-title":"Comparison of prophylactic use of intravenous immunoglobulin versus Pentaglobin\u00ae in pediatric patients after hematopoietic stem cell transplantation","volume":"20","author":"Azik","year":"2016","journal-title":"Pediatr Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117306328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117306328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:00:48Z","timestamp":1761058848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879117306328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1083879117306328"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.08.010","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A New Clinicobiological Scoring System for the Prediction of Infection-Related Mortality and Survival after Allogeneic Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}